Efficacies of Clarithromycin Regimens against Mycobacterium xenopi in Mice

Mice were infected intravenously with 3.5 × 10(7) CFU of Mycobacterium xenopi and treated with various clarithromycin-containing regimens or left untreated for 4 weeks. All nine of the clarithromycin-containing regimens reduced the CFU counts to the levels below the pretreatment values, indicating t...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Lounis, Nacer, Truffot-Pernot, Chantal, Bentoucha, Abdelhalim, Robert, Jerome, Ji, Baohong, Grosset, Jacques
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 2001
Témata:	Experimental Therapeutics
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90813/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11600387/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.11.3229-3230.2001
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!